Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association of Postnatal Dexamethasone Use and Fungal Sepsis in the Development of Severe Retinopathy of Prematurity and Progression to Laser Therapy in Extremely Low-Birth-Weight Infants

Abstract

OBJECTIVE: The objective of this study was to evaluate the role of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy and progression to laser therapy.

BACKGROUND: Postnatal steroids have been frequently used in the management of infants with chronic lung disease, airway edema, and hypotension, but their use is not free from adverse effects. Postnatal dexamethasone use has been associated with increased risk for the development of fungal sepsis, but the influence of glucocorticoid therapy on retinopathy of prematurity (ROP) is controversial. Candida sepsis has been shown to be associated with severe ROP and the need for laser therapy in some studies but not in others.

STUDY DESIGN: Medical records of all <1000 g birth weight infants ( n=158) admitted to Louisiana State University Health Sciences Center between July 1, 1996 and June 30, 1999 were reviewed. After exclusion of those infants who either died ( n=25) or transferred ( n=3) before eye examination, demographic and clinical data of 130 infants were analyzed by χ-squared analysis, Mann-Whitney U test, t-test, analysis of variance, and logistic regression. All data are mean±SD.

RESULTS: Gestational age was 26.4±1.7 weeks; birth weight was 797±130 g. Twenty-six infants were Caucasian, the rest African–American. Seventy-five (58%) received antenatal steroids. Eighty-eight (68%) of the infants received postnatal steroids. All infants were exclusively fed premature infant formulae. Sepsis developed in 44 (34%) infants and fungal sepsis in 14 (11%). Incidence of ROP was 77% (100/130), severe ROP (stage ≥3) 52% (68). Severe ROP was more frequent in Caucasian infants ( p=0.005) and in infants who received postnatal dexamethasone ( p≤0.0001). The development of threshold ROP (zone 1 or 2 with stage 3+, five contiguous or eight total clock hours of the retina) and requirement for laser therapy were higher in Caucasians ( p=0.0002) and in infants with fungal sepsis ( p=0.001). Antenatal steroids had no effect on the severity of ROP or the need for laser treatment. Postnatal dexamethasone use was significantly associated with fungal sepsis 13/14 (93%). After controlling for gestational age, race, days on supplemental oxygen, and fungal sepsis, cumulative postnatal dexamethasone use was independently associated with severe ROP [OR 1.2 (1.04–1.33)], and fungal sepsis [OR 8.2 (2.0–33.0)] was independently associated with the need for laser therapy.

CONCLUSIONS: Postnatal steroid use is an independent risk factor for development of severe ROP. The risk of threshold ROP requiring laser treatment was higher in infants who developed fungal sepsis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Evdokia Dimitriadis, Daniel L. Rolnik, … Ellen Menkhorst

Jonathan B. Lin, Raja Narayanan, … Rajendra S. Apte

References

  1. Gibson DL, Sheps SB, Uh SH, Schechter MT, McCormick AQ Retinopathy of prematurity-induced blindness: birth-weight-specific survival and the new epidemic Pediatrics 1990 86 405–12

    CAS  PubMed  Google Scholar 

  2. Valentine PH, Jackson JC, Kalina RE, Woodrum DE Increased survival of low-birth-weight infants: impact on the incidence of retinopathy of prematurity Pediatrics 1989 84 442–5

    CAS  PubMed  Google Scholar 

  3. Phelps DL Retinopathy of prematurity: an estimate of vision loss in the United States — 1979 Pediatrics 1981 67 924–6

    CAS  PubMed  Google Scholar 

  4. Phelps DL Retinopathy of prematurity Pediatr Clin North Am 1993 40 705–14

    Article  CAS  Google Scholar 

  5. Saunders RA, Donahue ML, Christmann LM, et al Racial variation in retinopathy of prematurity Arch Ophthalmol 1997 115 604–8

    Article  CAS  Google Scholar 

  6. Mittal M, Dhanireddy R, Higgins RD Candida sepsis and association with retinopathy of prematurity Pediatrics 1998 101 654–7

    Article  CAS  Google Scholar 

  7. Karlowicz MG, Giannone PJ, Pestian J, Morrow AL, Shults J Does candidemia predict threshold retinopathy of prematurity in extremely low-birth-weight (≤1000 g) neonates? Pediatrics 2000 105 1036–40

    Article  CAS  Google Scholar 

  8. Hickey SM, Mccracken G Jr Fungal and protozoal infections In: Fanaroff AA, Martin RJ, editors. Neonatal–Perinatal Medicine St. Louis, MO: Mosby Year Book 1997 pp. 759–61

  9. Batton DG, Roberts C, Trese M, Maisels MJ Severe retinopathy of prematurity and steroid exposure Pediatrics 1992 90 534–6

    CAS  PubMed  Google Scholar 

  10. Sobel DB, Philip AGS Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia Pediatrics 1992 90 529–33

    CAS  PubMed  Google Scholar 

  11. Wright K, Wright SP Lack of association of glucocorticoid therapy and retinopathy of prematurity Arch Pediatr Adolesc Med 1994 148 848–52

    Article  CAS  Google Scholar 

  12. Jacobs Monica AM, Blanco CE The incidence of retinopathy of prematurity and steroid therapy for bronchopulmonary dysplasia J Perinat Med 1998 26 13–6

    Article  Google Scholar 

  13. Committee for Classification of Retinopathy of Prematurity An international classification of retinopathy of prematurity Arch Ophthalmol 1984 102 1130–4

    Article  Google Scholar 

  14. Palmer EA, Flynn JT, Hardy RJ, et al Incidence and early course of retinopathy of prematurity Ophthalmology 1991 98 1628–40

    Article  CAS  Google Scholar 

  15. Uemera Y, Akiya S, Tsuchiya S Steroid-induced retinopathy Retinopathy of Prematurity Conference, December 1981 Ross Laboratories, Washington, DC 162

  16. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity Invest Ophthalmol Visual Sci 1996 37 290–9

    CAS  Google Scholar 

  17. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci USA 1995 92 905–9

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haroon Parupia, M., Dhanireddy, R. Association of Postnatal Dexamethasone Use and Fungal Sepsis in the Development of Severe Retinopathy of Prematurity and Progression to Laser Therapy in Extremely Low-Birth-Weight Infants. J Perinatol 21, 242–247 (2001). https://doi.org/10.1038/sj.jp.7200531

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7200531

This article is cited by

Search

Quick links